All News

h_swartz_2-4533-1408723618562.jpg

Farewell Harry!

Pharmaceutical Executive

When Harry Schwartz joined Pharmaceutical Executive for its inaugural issue in January 1981, he had already written 19 books and was well-known for his medical-related writings in the New York Times and other publications. Every month since then, without fail, he has faithfully supplied his At Large column, with its far-ranging analysis and commentary on political and business trends that affect the industry. Every magazine changes over time, and now a series of changes has brought an end to that distinguished, 20-year-long contribution.

Pharmaceutical Executive

My parents recently showed me an old news photo of my brother being moved from one hospital to another, in his iron lung. The year was 1950. Just seven years old, visibly smiling as usual in his overhead mirror, Gary lay prone as a small crowd of medics guided the huge wheeled cylinder toward a waiting ambulance. Polio had widely destroyed the motor neurons in his brain and spinal cord, and his muscles had atrophied from lying still. The iron lung pushed and pulled his chest through the breathing cycle. Gary lived only a few months after the photo's dateline.

Pharmaceutical Representative

According to the Greenwich, CT-based market research company InsightExpress, online consumers are staying away from online pharmacies.

Pharmaceutical Representative

First Horizon Pharmaceutical Corp. announced that it is expanding its sales force to provide the opportunity for coverage in excess of 70% of the nation.

Pharmaceutical Representative

Joanne St. John attributes her success in her three years as a sales rep for Princeton, NJ-based Novo Nordisk Pharmaceuticals to the freedom she has been given to determine her own strategies and take advantage of her personal background and skills.

Pharmaceutical Representative

More states are telling HMOs and other health insurers to pick up the tab for pharmaceuticals and other forms of obesity treatment.

Pharmaceutical Representative

Establishing and maintaining positive business relationships is a key challenge in selling to the growing number of foreign-born physicians practicing in North America.

Pharmaceutical Representative

The U.S. Department of Health and Human Services announced that it is proposing new rules to enable more low-income Americans to gain Medicaid coverage.

Pharmaceutical Representative

The Federal Trade Commission has announced that it will conduct a focused study of generic drug competition.

Pharmaceutical Representative

A new study, based on interviews with international headache experts and published by Waltham, MA-based Decision Resources Inc., predicts strong growth in the market for prescription drugs to treat migraines.

Pharmaceutical Representative

Half the people who have used the Internet to get health and medical information say this information has improved the way they take care of themselves.

Pharmaceutical Representative

The U.S. Department of Health and Human Services has released "Revised Guidelines for HIV Counseling, Testing and Referral" and "U.S. Public Health Service Recommendations for HIV Screening of Pregnant Women," two draft documents for public comment.

Pharmaceutical Representative

Healthcare was not the determining issue during last November's presidential election, but healthcare issues were on the minds of the voters.

Pharmaceutical Representative

The American Medical Association, more than 90 national provider and health organizations, and national, state and medical specialty associations encouraged the Institute of Medicine to support constructive learning and shared experience in the development of a properly constructed healthcare error reporting system.

Pharmaceutical Representative

By the time this issue of Pharmaceutical Representative reaches its readers, the new Prescription Drug Marketing Act regulations will finally have taken effect.

Pharmaceutical Representative

Total retail prescription drug sales for 2000 are expected to reach a record $143.5 billion, according to the National Association of Chain Drug Stores.

Pharmaceutical Representative

The FDA has suspended clinical trials at the Garden State Cancer Center until violations at the center are addressed.

Pharmaceutical Representative

Sales of drug delivery products are expected to increase by 100% over the next five years.

NIH teams with industry

Pharmaceutical Representative

A new initiative launched by the National Institutes of Health encourages private-sector involvement in attacking several of the world's most deadly infectious diseases.

Pharmaceutical Representative

Prescription drugs that are heavily advertised to consumers are responsible for the recent rise in pharmaceutical spending in the United States.

Pharmaceutical Representative

The increased use of medicines, not rising prices, is the cause of higher prescription drug spending.

Pharmaceutical Representative

The pharmaceutical industry is currently behind other brick-and-mortar industries in terms of e-business growth, but is moving rapidly to accelerate progress.

Pharmaceutical Representative

SmithKline Beecham and Block Drug Co. Inc. announced that the companies have signed agreements for SmithKline Beecham to acquire Block Drug.

Pharmaceutical Representative

The results of the first systematic program monitoring the quality of medical care provided to Medicare beneficiaries have been published in the Journal of the American Medical Association.

Pharmaceutical Representative

American Home Products Corp., Madison, NJ; Bristol-Myers Squibb Co., New York; Eli Lilly and Co., Indianapolis; Glaxo Wellcome Inc., Research Triangle Park, NC; Hoffman-La Roche Inc., Nutley, NJ; Merck & Co. Inc., Whitehouse Station, NJ; Novartis Pharmaceuticals Corp., East Hanover, NJ; Pfizer Inc., New York; Proctor & Gamble Co., Cincinnati; Schering-Plough Corp., Madison, NJ; SmithKline Beecham, Philadelphia; and Warner Lambert Co., Morris Plains, NJ were all named to Working Mother magazine's list of the "100 Best Companies for Working Mothers." Companies were rated on a scale of one to five (with five being the highest) in the following categories: childcare, flexibility, leave for new parents, work/life benefits and advancement of women. The list appeared in the October issue of the magazine.